BioCentury
ARTICLE | Company News

ImmuneWorks, United Therapeutics deal

February 15, 2010 8:00 AM UTC

United Therapeutics received exclusive, worldwide rights to develop and commercialize ImmuneWorks' IW001, with an option to acquire the company. ImmuneWorks will receive an undisclosed upfront payment. ...